FDA approves first treatment for Friedreich ’s ataxia

FDA has approved Skyclarys (omaveloxolone) as the first treatment for Friedreich ’s ataxia, a rare, inherited, degenerative disease that damages the nervous system, characterized by impaired coordination and walking.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news